Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality

Abstract

Outcome of patients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT) has improved. To investigate if this improvement can be transposed to the ICU setting, we conducted a systematic review and meta-analysis to assess short-term mortality of critically ill allo-HSCT patients admitted to the ICU and to identify prognostic factors of mortality. Public-domain electronic databases, including Medline via PubMed and the Cochrane Library were searched. All full-text articles written-English studies published from 2006 to 2016, including allo-HSCT adults transferred to the ICU were included. Eighteen studies were selected, including 2342 patients. Overall estimated ICU mortality was 51.7%. Prognostic factors associated with an increased ICU mortality were mechanical ventilation (OR = 12.2, 95% CI = 6.2–23.7), vasopressors (OR = 6.3, 95% CI = 3.6–11.1), renal replacement therapy (OR = 4.2, 95% CI = 2.8–6.2), ICU admission for acute respiratory failure (OR = 2.2, 95% CI = 1.1–4.4), acute kidney injury (OR = 2.2, 95% CI = 1.3–4), and acute graft-versus-host disease (OR = 1.6, 95% CI = 1.1–2.3). Factors associated with an increased ICU survival were a single-organ failure (OR = 0.2, 95% CI = 0.1–0.4), neurological failure (OR = 0.4, 95% CI = 0.2–0.8), and reduced-intensity conditioning regimens (OR = 0.7, 95% CI = 0.5–0.9). Septic shock, underlying malignancy, disease status, donor, and graft source did not impact prognosis. Outcome has improved, supporting the usefulness of ICU management. Organ failures at ICU admission, organ support requirement, and GVHD are the main prognostic factors.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med. 2007;357:1472–5.

    Article  CAS  Google Scholar 

  2. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–26.

    Article  CAS  Google Scholar 

  3. Gratwohl A, Schwendener A, Baldomero H, Gratwohl M, Apperley J, Niederwieser D, et al. Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology. Haematologica. 2010;95:637–43.

    Article  Google Scholar 

  4. Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303:1617–24.

    Article  CAS  Google Scholar 

  5. Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016;51:786–92.

    Article  CAS  Google Scholar 

  6. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628–33.

    Article  Google Scholar 

  7. Oudin C, Chevallier P, Furst S, Guillaume T, El CJ, Delaunay J, et al. Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies. Haematologica. 2014;99:1762–8.

    Article  CAS  Google Scholar 

  8. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363:2091–101.

    Article  CAS  Google Scholar 

  9. Naeem N, Reed MD, Creger RJ, Youngner SJ, Lazarus HM. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? Bone Marrow Transplant. 2006;37:119–33.

    Article  CAS  Google Scholar 

  10. Bayraktar UD, Nates JL. Intensive care outcomes in adult hematopoietic stem cell transplantation patients. World J Clin Oncol. 2016;7:98–105.

    Article  Google Scholar 

  11. Saillard C, Blaise D, Mokart D. Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant. 2016;51:1050–61.

    Article  CAS  Google Scholar 

  12. Rubenfeld GD, Crawford SW. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med. 1996;125:625–33.

    Article  CAS  Google Scholar 

  13. Azoulay E, Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med. 2006;32:3–5.

    Article  Google Scholar 

  14. Azoulay E, Pene F, Darmon M, Lengline E, Benoit D, Soares M, et al. Managing critically Ill hematology patients: time to think differently. Blood Rev. 2015;29:359–67.

    Article  Google Scholar 

  15. Mokart D, Pastores SM, Darmon M. Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med. 2014;40:1570–2.

    Article  Google Scholar 

  16. Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol. 2013;31:2810–8.

    Article  Google Scholar 

  17. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–28.

    Article  CAS  Google Scholar 

  18. Hill QA. Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Rev. 2010;24:17–25.

    Article  Google Scholar 

  19. Saillard C, Mokart D, Lemiale V, Azoulay E. Mechanical ventilation in cancer patients. Minerva Anestesiol. 2014;80:712–25.

    CAS  PubMed  Google Scholar 

  20. Lengline E, Chevret S, Moreau AS, Pene F, Blot F, Bourhis JH, et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2015;50:840–5.

    Article  CAS  Google Scholar 

  21. Magenau J, Runaas L, Reddy P. Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol. 2016;173:190–205.

    Article  Google Scholar 

  22. Mokart D, Granata A, Crocchiolo R, Sannini A, Chow-Chine L, Brun JP, et al. Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care. 2015;30:1107–13.

    Article  Google Scholar 

  23. Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006;24:643–9.

    Article  Google Scholar 

  24. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.

    Article  Google Scholar 

  25. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.

    Article  Google Scholar 

  26. Sorror ML. How I assess comorbidities before hematopoietic cell transplantation. Blood. 2013;121:2854–63.

    Article  CAS  Google Scholar 

  27. Cornelissen JJ, Blaise D. Hematopoietic stem cell transplantation for patients with AML in first complete remission. Blood. 2016;127:62–70.

    Article  CAS  Google Scholar 

  28. Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de LM, et al. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol. 2013;31:4207–14.

    Article  Google Scholar 

  29. Benz R, Schanz U, Maggiorini M, Seebach JD, Stussi G. Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2014;49:62–5.

    Article  CAS  Google Scholar 

  30. Canet E, Lengline E, Zafrani L, Peraldi MN, Socie G, Azoulay E. Acute kidney injury in critically ill allo-HSCT recipients. Bone Marrow Transplant. 2014;49:1121–2.

    Article  CAS  Google Scholar 

  31. Depuydt P, Kerre T, Noens L, Nollet J, Offner F, Decruyenaere J, et al. Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transplant. 2011;46:1186–91.

    Article  CAS  Google Scholar 

  32. Gilli K, Remberger M, Hjelmqvist H, Ringden O, Mattsson J. Sequential organ failure assessment predicts the outcome of SCT recipients admitted to intensive care unit. Bone Marrow Transplant. 2010;45:682–8.

    Article  CAS  Google Scholar 

  33. Lindgaard SC, Nielsen J, Lindmark A, Sengelov H. Prognosis of allogeneic haematopoietic stem cell recipients admitted to the intensive care unit: a retrospective, single-centre study. Acta Haematol. 2016;135:72–78.

    Article  CAS  Google Scholar 

  34. Mayer S, Pastores SM, Riedel E, Maloy M, Jakubowski AA. Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period. Leuk Lymphoma. 2016;58:1–9.

    Google Scholar 

  35. Moreau AS, Seguin A, Lemiale V, Yakoub-Agha I, Girardie P, Robriquet L, et al. Survival and prognostic factors of allogeneic hematopoietic stem cell transplant recipients admitted to intensive care unit. Leuk Lymphoma. 2014;55:1417–20.

    Article  Google Scholar 

  36. Naeem N, Eyzaguirre A, Kern JA, Lazarus HM, Hejal RB, Laughlin MJ, et al. Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit. Bone Marrow Transplant. 2006;38:733–8.

    Article  CAS  Google Scholar 

  37. Neumann F, Lobitz O, Fenk R, Bruns I, Kostering M, Steiner S, et al. The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol. 2008;87:299–304.

    Article  Google Scholar 

  38. Orvain C, Beloncle F, Hamel JF, Thepot S, Mercier M, Kouatchet A. Different impact of the number of organ failures and graft-versus-host disease on the outcome of allogeneic stem cell transplantation recipients requiring intensive care. Transplantation. 2017;101:437–44.

    Article  Google Scholar 

  39. Platon L, Amigues L, Ceballos P, Fegueux N, Daubin D, Besnard N, et al. A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013). Bone Marrow Transplant. 2016;51:256–61.

    Article  CAS  Google Scholar 

  40. Solh M, Oommen S, Vogel RI, Shanley R, Majhail NS, Burns LJ. A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. 2012;18:1378–84.

    Article  Google Scholar 

  41. Townsend WM, Holroyd A, Pearce R, Mackinnon S, Naik P, Goldstone AH, et al. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol. 2013;161:578–86.

    Article  Google Scholar 

  42. van Vliet M, van der Burgt MP, van der Velden WJ, van der Hoeven JG, de Haan AF, Donnelly JP, et al. Trends in the outcomes of Dutch haematological patients receiving intensive care support. Neth J Med. 2014;72:107–12.

    PubMed  Google Scholar 

  43. Fuchs EJ. Haploidentical transplantation for hematologic malignancies: where do we stand? Hematol Am Soc Hematol Educ Program. 2012;2012:230–6.

    Google Scholar 

  44. Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med. 2010;182:1038–46.

    Article  Google Scholar 

  45. Azoulay E, Schlemmer B. Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med. 2006;32:808–22.

    Article  Google Scholar 

  46. Azoulay E, Lemiale V. Non-invasive mechanical ventilation in hematology patients with hypoxemic acute respiratory failure: a false belief? Bone Marrow Transplant. 2012;47:469–72.

    Article  CAS  Google Scholar 

  47. Lemiale V, Resche-Rigon M, Mokart D, Pene F, Rabbat A, Kouatchet A, et al. Acute respiratory failure in patients with hematological malignancies: outcomes according to initial ventilation strategy. A groupe de recherche respiratoire en reanimation onco-hematologique (Grrr-OH) study. Ann Intensive Care. 2015;5:28.

    Article  Google Scholar 

  48. Mokart D, Geay C, Chow-Chine L, Brun JP, Faucher M, Blache JL. High-flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med. 2015;41:2008–10.

    Article  Google Scholar 

  49. Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–96.

    Article  CAS  Google Scholar 

  50. Lemiale V, Mokart D, Resche-Rigon M, Pene F, Mayaux J, Faucher E, et al. Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA. 2015;314:1711–9.

    Article  CAS  Google Scholar 

  51. Tichelli A, Bhatia S, Socie G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol. 2008;142:11–26.

    Article  Google Scholar 

  52. Larche J, Azoulay E, Fieux F, Mesnard L, Moreau D, Thiery G, et al. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med. 2003;29:1688–95.

    Article  Google Scholar 

  53. Lecuyer L, Chevret S, Guidet B, Aegerter P, Martel P, Schlemmer B, et al. Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J. 2008;32:748–54.

    Article  CAS  Google Scholar 

  54. Pene F, Percheron S, Lemiale V, Viallon V, Claessens YE, Marque S, et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med. 2008;36:690–6.

    Article  Google Scholar 

  55. Zuber B, Tran TC, Aegerter P, Grimaldi D, Charpentier J, Guidet B, et al. Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med. 2012;40:55–62.

    Article  Google Scholar 

  56. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.

    Article  CAS  Google Scholar 

  57. Hong KT, Kang HJ, Kim NH, Kim MS, Lee JW, Kim H, et al. Peri-engraftment syndrome in allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48:523–8.

    Article  CAS  Google Scholar 

  58. Hingorani S. Renal complications of hematopoietic-cell transplantation. N Engl J Med. 2016;374:2256–67.

    Article  Google Scholar 

  59. Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, et al. Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplant. 2016;51:906–12.

    Article  CAS  Google Scholar 

  60. Carreras E, Granena A, Navasa M, Bruguera M, Marco V, Sierra J, et al. Transjugular liver biopsy in BMT. Bone Marrow Transplant. 1993;11:21–6.

    CAS  PubMed  Google Scholar 

  61. Siegal D, Keller A, Xu W, Bhuta S, Kim DH, Kuruvilla J, et al. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant. 2007;13:1369–79.

    Article  Google Scholar 

  62. de ME, Tandjaoui-Lambiotte Y, Legrand M, Lambert J, Mokart D, Kouatchet A, et al. Outcomes in critically ill cancer patients with septic shock of pulmonary origin. Shock. 2013;39:250–4.

    Article  Google Scholar 

  63. Lengline E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N, et al. Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma. 2012;53:1352–9.

    Article  Google Scholar 

  64. Mokart D, Lambert J, Schnell D, Fouche L, Rabbat A, Kouatchet A, et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma. 2013;54:1724–9.

    Article  Google Scholar 

  65. Song JU, Suh GY, Park HY, Lim SY, Han SG, Kang YR, et al. Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units. Intensive Care Med. 2012;38:1505–13.

    Article  Google Scholar 

  66. Hayani O, Al-Beihany A, Zarychanski R, Chou A, Kharaba A, Baxter A, et al. Impact of critical care outreach on hematopoietic stem cell transplant recipients: a cohort study. Bone Marrow Transplant. 2011;46:1138–44.

    Article  CAS  Google Scholar 

  67. Jones DA, DeVita MA, Bellomo R. Rapid-response teams. N Engl J Med. 2011;365:139–46.

    Article  CAS  Google Scholar 

  68. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9.

    Article  CAS  Google Scholar 

  69. Byrne M, Savani BN, Mohty M, Nagler A. Peripheral blood stem cell versus bone marrow transplantation: a perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Exp Hematol. 2016;44:567–73.

    Article  Google Scholar 

  70. Holtan SG, Pasquini M, Weisdorf DJ. Acute graft-versus-host disease: a bench-to-bedside update. Blood. 2014;124:363–73.

    Article  CAS  Google Scholar 

  71. Azoulay E, Lemiale V, Mokart D, Pene F, Kouatchet A, Perez P, et al. Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med. 2014;40:1106–14.

    Article  Google Scholar 

  72. Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29:191–204.

    Article  Google Scholar 

  73. Vrhovac R, Labopin M, Ciceri F, Finke J, Holler E, Tischer J, et al. Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes. Bone Marrow Transplant. 2016;51:186–93.

    Article  CAS  Google Scholar 

  74. Kahn JM, Goss CH, Heagerty PJ, Kramer AA, O’Brien CR, Rubenfeld GD. Hospital volume and the outcomes of mechanical ventilation. N Engl J Med. 2006;355:41–50.

    Article  CAS  Google Scholar 

  75. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323:224–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Colombe Saillard.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Registered on PROSPERO (http://www.crd.york.ac.uk/PROSPERO/, number 42016047307).

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saillard, C., Darmon, M., Bisbal, M. et al. Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality. Bone Marrow Transplant 53, 1233–1241 (2018). https://doi.org/10.1038/s41409-018-0181-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-018-0181-x

This article is cited by

Search

Quick links